Moreover, the pharmacological effects of cisplatin (DDP), a chemotherapy agent used to inhibit tumor growth in vivo, are reduced by the overexpression of BRD4, suggesting that BRD4 could serve as a novel therapeutic target for bladder cancer.57 This evidence concerns the gene BRD4 and neoplasm.